Direct-to-consumer advertising of prescription drugs: Balancing benefits and risks, and a way forward

Clinical Pharmacology and Therapeutics

Volumn 82, Issue 4, 2007, Pages 360-362

  Kravitz, R L ^a   Bell, R A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ROFECOXIB; ROSIGLITAZONE; TEGASEROD;

CONSUMER; DIRECT TO CONSUMER ADVERTISING; DOCTOR PATIENT RELATION; DRUG BIOAVAILABILITY; DRUG COST; DRUG INDUSTRY; DRUG MARKETING; DRUG SAFETY; EVIDENCE BASED MEDICINE; FOOD AND DRUG ADMINISTRATION; HEART DISEASE; IRRITABLE COLON; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ADVOCACY; PHYSICIAN; POSTMARKETING SURVEILLANCE; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RISK; SHORT SURVEY;

CONSUMER PRODUCT SAFETY; DRUG AND NARCOTIC CONTROL; DRUG INDUSTRY; DRUG INFORMATION SERVICES; DRUG THERAPY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HUMANS; MARKETING OF HEALTH SERVICES; MASS MEDIA; MODELS, ECONOMETRIC; PATIENT EDUCATION; PERSUASIVE COMMUNICATION; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN'S ROLE; PRESCRIPTIONS, DRUG; PRODUCT SURVEILLANCE, POSTMARKETING; RISK ASSESSMENT;

EID: 34548698894     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/sj.clpt.6100348     Document Type: Short Survey

References (9)

1. Mintzes, B. et al. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. CMAJ 169, 405-412 (2003).
2. Weisman, J.S. et al. Consumers' reports on the health effects of direct-to-consumer drug advertising. Health Aff. (Millwood), W4, 219-233 (28 April 2004).
3. Frosch, D.L., Krueger, P.M., Hornik, R.C., Cronholm, P.F. & Barg, F.K. Creating demand for prescription drugs: a content analysis of television direct-to-consumer advertising. Ann. Fam. Med. 5, 6-13 (2007).
4. Bell, R.A., Wilkes, M.S. & Kravitz, R.L. The educational value of consumer-targeted prescription drug print advertising. J. Fam. Pract. 49, 1092-1098 (2000).
5. Stange, K.C. Time to ban direct-to-consumer prescription drug marketing. Ann. Fam. Med. 5, 101-104 (2007).
6. Shuchman, M. Drug risks and free speech: can Congress ban consumer drug ads? N. Engl. J. Med. 356, 2236-2239 (2007).
7. Almasi, E.A., Stafford, R.S., Kravitz, R.L. & Mansfield, P.R. What are the public health effects of direct-to-consumer drug advertising? PLoS Med. 3, e145 (2006).
8. Thavendiranathan, P., Bagai, A., Brookhart, M.A. & Choudhry, N.K. Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 166, 2307-2313 (2006).
9. Vrecer M, Turk S, Drinovec J, Mrhar A. Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials. Int. J. Clin. Pharmacol. Ther. 41, 567-577 (2003).